South East Asia Swine Vaccines Market
市场规模（十亿美元）
CAGR :
% 
USD
1.06 Billion
USD
1.73 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 1.06 Billion |
 Market Size (Forecast Year) |
USD 1.73 Billion |
 CAGR |
% |
| Major Markets Players |
|
東南亞豬疫苗市場細分，按病原體（病毒和細菌）、適應症（豬繁殖與呼吸綜合症 (PRRS)、豬圓環病毒相關疾病 (PCV/PCVD)、豬瘟、口蹄疫(FMD)、豬肺炎、豬細小病毒、副豬革蘭氏桿菌等）、技術（滅活疫苗、重組疫苗、減毒活疫苗、類毒素疫苗等）、產品（Ingelvac、Porcilis、Improvac、Prevacent、Enterisol、Cirbloc M Hyo、Bioaftogen、Enradin、Ycyocoin、Cirhom、Ciran Hyo、Bioaftogen、Enradin、Ycyocoin、Caijam、Han Hyo、Bioaftogen、Enin、Ycyofin、Cain、Ycan Hyo、Sporcg、Zradin、Ycyofin、Cain、Ycan Hyo、Bioaftogen、Enin、Ycyofin、Cain、Ycan Hyo、Sporcg、Zradin、Ycyocoin、Cain、Ycman Hyo、Bioaftogen、Enguan、Ycyo、Cain、Ycyo、Cain、Ycmone、Caknone、Ycoo 它、 它份Shiga、Parvoruvax、Enteroporc Coli Ac、Navet-Asfvac 和 Avac Asf Live、 Coglapix、Progressis、瑞蘭、Vepured、Suigen、Shield、瑞福特王、Refute、瑞元舒、清虛靈等）、人口統計（仔豬和成人）、給藥途徑（肌肉注射、皮下注射、其他）、分銷渠道（醫院和診所、零售藥店、電子商務平台等）——行業趨勢和預測至2032年
豬疫苗市場規模
- 2024 年東南亞豬疫苗市場規模為10.6 億美元，預計到 2032 年將達到 17.3 億美元，預測期內 複合年增長率為 6.3%。
- 這種增長是由豬病發病率上升等因素推動的
豬疫苗市場分析
- 豬疫苗在東南亞豬疫苗市場中發揮著至關重要的作用，是預防豬群疾病的重要工具。這些疫苗有助於改善牲畜健康和生產力，支持該地區的農業產業並確保糧食安全。它們對於控制疫情和減少經濟損失尤其重要
- 這些顯微鏡的需求很大程度是由於東南亞國家豬病發生率上升、豬肉消費量增加
- 由於中國畜牧業的不斷擴張和先進獸醫保健實踐的日益普及，中國預計將佔據豬疫苗市場的 45.24% 份額
- 由於對有效疫苗接種解決方案的需求不斷增加以及對豬隻健康管理意識的不斷增強，預計中國將成為預測期內豬疫苗市場成長最快的地區
- 病毒領域預計將佔據市場主導地位，市場份額為 66.58%，因為其流行率很高，而且對預防豬群病毒性疾病的有效疫苗解決方案的需求不斷增長
報告範圍和豬疫苗市場細分
|
屬性 |
豬疫苗關鍵市場洞察 |
|
涵蓋的領域 |
|
|
覆蓋國家 |
東南亞
|
|
主要市場參與者 |
|
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。 |
豬疫苗市場趨勢
“疫苗接種技術和接種方法的進步”
- 東南亞豬疫苗市場發展的一個突出趨勢是創新疫苗配方和給藥方法的不斷發展
- 這些進步透過提供更廣泛的保護和更有效的管理提高了免疫效果，從而增強了該地區整體畜群健康管理
- 例如，東南亞豬疫苗市場的現代疫苗開發和交付技術提供了增強的免疫反應和更廣泛的群體免疫，有助於更好地控制和預防疾病
- 這些進步正在改變豬隻的健康管理，提高牲畜的整體生產力，並推動對具有更高功效和創新給藥方法的下一代疫苗的需求
豬疫苗市場動態
司機
“豬病發生率上升”
- 豬隻病發病率不斷上升，尤其是非洲豬瘟 (ASF)、豬繁殖與呼吸綜合症病毒 (PRRSV) 和豬流行性腹瀉病毒 (PEDV)，對東南亞養豬業產生了重大影響
- 隨著豬隻病爆發的頻率和嚴重程度不斷增加，對有效疫苗的需求也越來越大，東南亞豬疫苗市場將迎來大幅成長
- 隨著越來越多的豬群接種疫苗以預防傳染病，對有效疫苗的需求也在增加，以確保更好的豬群健康並降低東南亞地區疾病爆發的風險
例如，
- 2020年7月，根據NCBI發表的文章稱，非洲豬瘟病毒（ASFV）、PRRSV、PEDV、FMDV等豬病發病率的上升持續嚴重影響著佔全球生豬存欄量50%以上的亞洲養豬業。多樣化的生產系統、動物流動和全球化等因素加劇了疾病的快速傳播，推動了東南亞市場對有效豬隻疫苗的強勁需求
- 因此，豬病爆發的頻率和嚴重程度不斷增加，推動了對有效疫苗的迫切需求，東南亞豬疫苗市場將迎來大幅成長
機會
“疫苗技術的創新”
- 傳統疫苗已得到 DNA 和 mRNA 疫苗等新方法的補充，這些新方法可以更快地開發並適應新出現的病原體。這些下一代疫苗有望提高安全性和有效性，縮短生產時間並提高穩定性
- 此外，人們正在探索以載體為基礎的疫苗，即使用無害病毒來傳遞抗原，以期誘導更強的免疫反應。佐劑也得到了進化，透過增強免疫系統的反應來提高疫苗的有效性
- 此外，口服和無針疫苗輸送系統提高了給藥的便利性和動物福利。這些進步旨在控制豬隻繁殖與呼吸綜合症（PRRS）等地方性疾病，改善豬群整體健康狀況，從而提高養豬業的生產力和盈利能力
例如，
- 2025 年 3 月，MDPI 發表的一篇文章重點介紹了非洲豬瘟控制的關鍵創新，包括開發 ASFV-G-ΔI177L 等減毒活疫苗、RPA 檢測等快速診斷工具以及建模群體免疫閾值。這些進展旨在改善預防和控制策略，特別是針對東南亞的小型養豬場
- 該地區的疫苗研發正在蓬勃發展，特別是針對藍耳病、豬瘟和其他地方病的疫苗。政府推動生物安全的措施以及對農民進行疫苗接種益處的教育正在推動市場擴張
克制/挑戰
“疫苗接種方案的複雜性及其影響因素”
- 東南亞豬疫苗市場的一個重大限制因素是疫苗接種方案的複雜性以及對疫苗效力產生負面影響的各種因素
- 這些因素包括壓力、微生物群變化和母源抗體 (MDA)，這些因素都會幹擾免疫反應。雖然有些因素已被充分了解，但許多因素仍未得到充分研究，對疫苗的有效性產生了不確定性。
- 缺乏全面的知識導致動物主人和獸醫產生懷疑，削弱了人們對疫苗作為抗生素可行替代品的信心
例如，
- 2024年8月，根據MDPI發表的文章，疫苗接種方案的複雜性，包括需要嚴格的生物安全措施和全面的監測，影響了東南亞疫苗的有效性。正如世界愛滋病日的擔憂和現場疫苗相關病毒的出現所強調的那樣，不正確的疫苗使用會導致重大挑戰。缺乏標準化的疫苗評估方案和獨立的機構，阻礙了有效的疾病控制，限制了東南亞豬疫苗市場的發展
- 疫苗接種方案的複雜性，加上壓力、微生物組變異和母源抗體（MDA）等因素，對東南亞養豬業疫苗的有效應用提出了重大挑戰
豬疫苗市場範圍
市場根據病原體、適應症、技術、產品、人口統計、給藥途徑和分銷管道進行細分。
|
分割 |
細分 |
|
依病原體 |
|
|
按適應症 |
|
|
按產品 |
|
|
按人口統計
|
|
|
依給藥途徑 |
|
|
按分銷管道
|
|
預計到 2025 年，病毒將佔據市場主導地位，在應用領域佔有最大份額
由於豬群中病毒性疾病的盛行率很高，且對有針對性的疫苗接種解決方案的需求不斷增長，預計到 2025 年，病毒類疫苗將佔據豬疫苗市場的主導地位，佔據 66.58% 的最大份額。作為預防疾病的關鍵措施，疫苗技術和免疫策略的進步有望提高療效並促進市場成長。人們對動物健康管理和政府計劃的認識不斷提高，進一步增強了其市場主導地位。
預計豬繁殖與呼吸綜合症（PRRS）將在預測期內佔據技術領域的最大份額
到 2025 年，豬隻繁殖與呼吸綜合症 (PRRS) 領域預計將佔據市場主導地位，市場份額最大，為 24.29%，原因是該患者病率高且對有效疫苗接種解決方案的需求大。作為對豬隻健康的一個主要關注點，疫苗開發和免疫方案的進步有望加強疾病控制，推動市場成長。人們對生物安全措施和政府措施的認識不斷提高，進一步增強了其市場主導地位。
豬疫苗市場區域分析
“中國佔豬疫苗市場最大份額”
- 中國佔據豬疫苗市場的主導地位，市場份額達 45.24%，這得益於牲畜數量的增加、動物衛生基礎設施投資的增加以及主要區域市場參與者的存在
- 由於人們對豬病管理的認識不斷提高、政府採取措施改善牲畜健康，以及豬群中病毒和細菌感染的流行率不斷上升，中國佔據了相當大的份額
- 動物保健支持政策的推出和製藥公司對研發的投入不斷增加進一步增強了市場。
- 此外，對自動化疫苗接種系統和改進的生物安全措施的需求不斷增長，以及工業化養豬業的興起，正在推動整個地區的市場成長
“預計中國將在豬疫苗市場實現最高複合年增長率”
- 預計中國豬疫苗市場將出現大幅增長，這得益於動物健康管理實踐的日益普及、畜牧業的不斷擴張以及疾病預防意識的不斷提高
- 泰國、越南和印尼等國家由於生豬數量不斷增長、豬病發病率不斷上升以及政府採取措施提高動物健康標準，正在成為主要市場
- 越南和泰國隨著生豬養殖業的不斷擴大和對獸醫保健的投資不斷增加，正在成為豬隻疫苗的重要市場。對生物安全和疾病控制措施的關注繼續推動市場擴張
- 此外，對安全有效的疫苗接種計劃的需求不斷增長，加上全球製藥公司的存在和獸醫基礎設施的改善，進一步推動了東南亞市場的成長
豬疫苗市場份額
市場競爭格局提供了競爭對手的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投資、新市場計劃、全球影響力、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度、應用優勢。以上提供的數據點僅與公司對市場的關注有關。
市場中主要的市場領導者有：
- 勃林格殷格翰國際有限公司（德國）
- 默克公司（美國）
- 碩騰公司（美國）
- Ceva（法國）
- 普萊柯生物工程股份有限公司 (中國)
- Elanco Animal Health Incorporated（美國）
- Biogenesis Bagó SA（阿根廷）
- HIPRA, SA（西班牙）
- 金宇生物科技股份有限公司 (中國)
- 上海申聯生物醫藥股份有限公司（中國）
- 中牧實業股份有限公司 (中國)
- ESCO ASTER 私人有限公司有限公司（新加坡）
- 上海海利生物科技有限公司 (中國)
- AVAC越南股份公司（越南）
- Bimeda Biologicals Ltd.（愛爾蘭）
- 哈爾濱哈維克生物科技有限公司 (中國)
- Virbac SA（法國）
東南亞豬疫苗市場最新動態
- 2024年11月，勃林格殷格翰公司推出的犬隻鉤端螺旋體病疫苗旨在預防導致此疾病的鉤端螺旋體細菌。這種疫苗可以對最常見的鉤端螺旋體菌株產生免疫力，這種菌株會導致嚴重的肝臟和腎臟損害，甚至可能致命。透過給狗接種疫苗，寵物主人可以顯著降低因接觸受污染的水或土壤而感染的風險。該疫苗可提供持久保護，有助於狗的整體健康，並防止疾病傳播給其他動物或人類，從而為寵物及其家人提供更安全的環境
- 2024 年 11 月，勃林格殷格翰推出針對患有充血性心臟衰竭 (CHF) 的狗的 Vetmedin 口服溶液。這種新配方提供了一種易於管理的解決方案，可以改善患有 CHF 的狗的心臟功能，CHF 是一種通常由二尖瓣疾病或擴張型心肌病變引起的疾病。 Vetmedin 的作用是增強心臟泵血能力，減輕咳嗽、疲勞和呼吸困難等症狀。該解決方案提供了一種便捷的治療選擇，有助於提高患犬的生活品質和壽命，使心臟衰竭管理更加有效，寵物主人和獸醫都能更容易獲得
- 9 月，默克動物保健公司獲得了歐盟對 PORCILIS PCV M Hyo ID 的上市許可，這是一種皮內注射、無針豬疫苗，可預防 PCV2 和 M. hyo。透過 IDAL 技術交付，它提供高效、低容量的管理並增強動物福利。該疫苗將於 2025 年第一季上市，支持永續性、與其他疫苗合併使用，並增強仔豬的疾病防護
- 2020 年 7 月，碩騰從 Benchmark Holdings 收購了 Fish Vet Group，以增強其 Pharmaq 水產養殖業務。此次收購擴大了 Pharmaq 在英國、挪威、愛爾蘭和智利等主要市場的診斷和環境測試能力。 Fish Vet Group 的服務透過協助疾病管理、環境合規和場地評估來支持永續水產養殖，從而增強了 Zoetis 在全球魚類健康解決方案中的地位
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE SOUTH EAST ASIA SWINE VACCINE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 SECONDARY SOURCES
2.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 DRUG TREATMENT RATE BY MATURED MARKETS
4.4 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
4.5 PATIENT FLOW DIAGRAM
4.6 KEY PRICING STRATEGIES
4.7 KEY PATIENT ENROLLMENT STRATEGIES
4.8 MARKETED DRUG ANALYSIS
4.9 AVERAGE PRICED PAID FOR A VACCINE DOSE
4.1 HEALTHCARE TARIFFS IMPACT ANALYSIS
4.10.1 OVERVIEW
4.10.2 TARIFF STRUCTURES
4.10.2.1 GLOBAL VS. REGIONAL TARIFF STRUCTURES
4.10.2.2 UNITED STATES: MEDICARE/MEDICAID TARIFF POLICIES, CMS PRICING MODELS
4.10.2.3 EUROPEAN UNION: CROSS-BORDER TARIFF REGULATIONS, REIMBURSEMENT POLICIES
4.10.2.4 ASIA-PACIFIC: GOVERNMENT-IMPOSED TARIFFS ON IMPORTED MEDICAL PRODUCTS
4.10.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
4.10.3 PHARMACEUTICAL TARIFFS AND TRADE BARRIERS
4.10.3.1 IMPORT DUTIES ON PRESCRIPTION DRUGS VS. GENERICS
4.10.3.2 IMPACT ON DRUG AFFORDABILITY AND ACCESS
4.10.3.3 KEY TRADE AGREEMENTS AFFECTING PHARMACEUTICAL TARIFFS
4.10.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND PATIENTS
4.10.4.1 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES
4.10.4.2 EFFECT ON PATIENT AFFORDABILITY AND INSURANCE COVERAGE
4.10.4.3 TARIFFS AND THEIR ROLE IN MEDICAL TOURISM
4.10.5 TRADE AGREEMENTS AND HEALTHCARE TARIFFS
4.10.5.1 WTO REGULATIONS ON HEALTHCARE TARIFFS
4.10.5.2 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN
4.10.5.3 ROLE OF FREE TRADE AGREEMENTS (FTAs) IN REDUCING TARIFFS
4.10.6 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY
4.10.7 IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
5 EPIDEMIOLOGICAL OVERVIEW OF KEY SWINE DISEASES IN THE SOUTH EAST ASIA (SEA) SWINE VACCINE MARKET:
5.1 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS)
5.2 PORCINE CIRCOVIRUS ASSOCIATED DISEASE (PCV/PCVD)
5.3 FOOT-AND-MOUTH DISEASE (FMD)
5.4 AFRICAN SWINE FEVER (ASF)
5.5 CLASSICAL SWINE FEVER (CSF)
5.6 PORCINE PARVOVIRUS (PPV)
5.7 PORCINE PNEUMONIA
5.8 GLAESSERELLA PARASUIS (GLÄSSER’S DISEASE)
6 MARKET OVERVIEW
6.1 DRIVER
6.1.1 RISING INCIDENCE OF SWINE DISEASES.
6.1.2 HIGHER PORK CONSUMPTION ACROSS SOUTHEAST ASIAN COUNTRIES.
6.1.3 INCREASE IN PORK EXPORTS FROM SOUTHEAST ASIA.
6.2 RESTRAINT
6.2.1 COMPLEXITY OF VACCINATION PROTOCOLS AND FACTORS AFFECTING EFFICACY AS A RESTRAINT
6.2.2 LACK OF ADEQUATE COLD CHAIN LOGISTICS.
6.3 OPPORTUNITIES
6.3.1 INNOVATIONS IN VACCINE TECHNOLOGIES
6.3.2 URGENT NEED FOR ENHANCED DISEASE PREVENTION IN SWINE PRODUCTION
6.3.3 IMPROVED DIAGNOSTICS AND MONITORING
6.4 CHALLENGES
6.4.1 COMPETITION FROM ALTERNATIVE DISEASE MANAGEMENT STRATEGIES
6.4.2 LOW INVESTMENT IN DISEASE SURVEILLANCE FOR SWINE IN ASIA
7 SOUTH EAST ASIA SWINE VACCINES MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 INACTIVATED VACCINES
7.3 RECOMBINANT VACCINES
7.4 LIVE ATTENUATED VACCINES
7.5 TOXOID VACCINES
7.6 OTHERS
8 SOUTH EAST ASIA SWINE VACCINES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INGELVAC
8.2.1 PARVORUVAX
8.2.2 ENTEROPORC COLI AC
8.2.3 NAVET-ASFVAC & AVAC ASF LIVE
8.2.4 COGLAPIX
8.3 PORCILIS
8.3.1 CSF LIVE
8.3.2 APP
8.3.3 AR-T
8.3.4 GLASSER
8.3.5 PARVO
8.3.6 PORCOLI DF
8.3.7 BEGONIA
8.4 IMPROVAC
8.5 PREVACENT
8.6 ENTERISOL
8.7 CIRBLOC M HYO
8.8 BIOAFTOGEN
8.9 ENRADIN
8.1 YUAN KE XIN
8.11 CIRCOVAC
8.12 HYOGEN
8.13 SALMOPORC
8.14 ECOPORC
8.15 PARVORUVAX
8.16 ENTEROPORC COLI AC
8.17 NAVET-ASFVAC & AVAC ASF LIVE
8.18 COGLAPIX
8.19 PROGRESSIS
8.2 RUILAN
8.21 VEPURED
8.22 SUIGEN
8.23 SHIELD
8.23.1 PARVO SHIELD
8.23.2 PARA SHIELD
8.23.3 RHINI SHIELD
8.23.4 PILI SHIELD
8.24 RUIFUTE-WANG
8.25 REFUTE
8.26 RUIYUANSHU
8.27 CLEAR THE FALSE SPIRIT
8.28 OTHERS
9 SOUTH EAST ASIA SWINE VACCINES MARKET, BY PATHOGEN
9.1 OVERVIEW
9.2 VIRUS
9.3 BACTERIA
10 SOUTH EAST ASIA SWINE VACCINES MARKET, BY INDICATION
10.1 OVERVIEW
10.2 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS)
10.3 PORCINE CIRCOVIRUS ASSOCIATED DISEASE (PCV/PCVD)
10.4 SWINE FEVER
10.4.1 CLASSICAL SWINE FEVER (CSF)
10.4.2 AFRICAN SWINE FEVER (ASF)
10.5 FOOT-AND-MOUTH DISEASE (FMD)
10.6 PORCINE PNEUMONIA
10.7 PORCINE PAROVIRUS
10.8 GLAESSERELLA PARASUIS
10.9 OTHERS
11 SOUTH EAST ASIA SWINE VACCINE MARKET, BY DEMOGRAPHIC
11.1 OVERVIEW
11.2 PIGLET
11.3 ADULT
12 SOUTH EAST ASIA SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION,
12.1 OVERVIEW
12.2 INTRAMUSCULAR
12.3 SUBCUTANEOUS
12.4 OTHERS
13 SOUTH EAST ASIA SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 HOSPITALS AND CLINICS
13.3 RETAIL PHARMACIES
13.4 E-COMMERCE PLATFORMS
13.5 OTHERS
14 SOUTH EAST ASIA SWINE VACCINES MARKET, BY COUNTRY
14.1 SOUTH EAST ASIA
14.1.1 CHINA
14.1.2 THAILAND
14.1.3 VIETNAM
14.1.4 PHILIPPINES
14.1.5 SOUTH KOREA
14.1.6 TAIWAN
14.1.7 REST OF SOUTH EAST ASIA
15 SOUTH EAST ASIA SWINE VACCINES MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: SOUTH EAST ASIA
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 BOEHRINGER INGELHEIM GMBH
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 MERCK & CO., INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT/NEWS
17.3 ZOETIS SERVICES LLC.
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 JINYU BIOTECHNOLOGY CO., LTD
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 CEVA
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENT
17.6 BIMEDA BIOLOGICALS
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT UPDATES
17.7 BIMEDA BIOLOGICALS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT UPDATES
17.8 BIOGÉNESIS BAGÓ
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT UPDATES
17.9 CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 ELANCO
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT/NEWS
17.11 ESCO ASTER PTE. LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT UPDATES
17.12 HARBIN HARVAC BIOTECHNOLOGY CO. LTD
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 HIPRA
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT UPDATES
17.14 PULIKE BIOLOGICAL ENGINEERING
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 SHANGHAI HAILI BIOTECHNOLOGY CO., LTD.
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT UPDATES
17.17 VIRBAC
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 GLOBAL CLINICAL TRIAL MARKET FOR SWINE VACCINE
TABLE 2 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE – GLOBAL SWINE VACCINE MARKET
TABLE 3 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE – GLOBAL SWINE VACCINE MARKET
TABLE 4 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE – GLOBAL SWINE VACCINE MARKET
TABLE 5 EPIDEMIOLOGY OF SWINE DISEASES IN SOUTHEAST ASIA
TABLE 6 SOUTH EAST ASIA SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 7 SOUTH EAST ASIA SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 8 SOUTH EAST ASIA INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 9 SOUTH EAST ASIA PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 10 SOUTH EAST ASIA SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 11 SOUTH EAST ASIA SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 12 SOUTH EAST ASIA SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 13 SOUTH EAST ASIA SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 14 SOUTH EAST ASIA SWINE VACCINE MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 15 SOUTH EAST ASIA SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 16 SOUTH EAST ASIA SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 17 SOUTH EAST ASIA SWINE VACCINES MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18 SOUTH EAST ASIA SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 19 SOUTH EAST ASIA SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 20 SOUTH EAST ASIA SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 21 SOUTH EAST ASIA SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 22 SOUTH EAST ASIA SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 23 SOUTH EAST ASIA INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 24 SOUTH EAST ASIA PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 25 SOUTH EAST ASIA SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 26 SOUTH EAST ASIA SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 27 SOUTH EAST ASIA SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 28 SOUTH EAST ASIA SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 29 CHINA SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 30 CHINA SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 31 CHINA SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 32 CHINA SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 33 CHINA SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 34 CHINA INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 35 CHINA PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 36 CHINA SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 37 CHINA SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 38 CHINA SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 39 CHINA SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40 THAILAND SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 41 THAILAND SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 42 THAILAND SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 43 THAILAND SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 44 THAILAND SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 45 THAILAND INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 46 THAILAND PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 47 THAILAND SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 48 THAILAND SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 49 THAILAND SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 50 THAILAND SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 51 VIETNAM SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 52 VIETNAM SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 53 VIETNAM SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 54 VIETNAM SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 55 VIETNAM SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 56 VIETNAM INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 57 VIETNAM PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 58 VIETNAM SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 59 VIETNAM SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 60 VIETNAM SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 61 VIETNAM SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 62 PHILIPPINES SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 63 PHILIPPINES SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 64 PHILIPPINES SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 65 PHILIPPINES SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66 PHILIPPINES SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 67 PHILIPPINES INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 68 PHILIPPINES PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 69 PHILIPPINES SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 70 PHILIPPINES SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 71 PHILIPPINES SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 72 PHILIPPINES SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73 SOUTH KOREA SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 74 SOUTH KOREA SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 75 SOUTH KOREA SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 76 SOUTH KOREA SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 77 SOUTH KOREA SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 78 SOUTH KOREA INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 79 SOUTH KOREA PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 80 SOUTH KOREA SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 81 SOUTH KOREA SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 82 SOUTH KOREA SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 83 SOUTH KOREA SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84 TAIWAN SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
TABLE 85 TAIWAN SWINE VACCINES MARKET, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 86 TAIWAN SWINE FEVER IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 87 TAIWAN SWINE VACCINES MARKET, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 88 TAIWAN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 89 TAIWAN INGELVAC IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 90 TAIWAN PORCILIS IN SWINE VACCINES MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 91 TAIWAN SHIELD IN SWINE VACCINES MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 92 TAIWAN SWINE FEVER IN SWINE VACCINES MARKET, BY DEMOGRAPHIC, 2018-2032 (USD MILLION)
TABLE 93 TAIWAN SWINE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 94 TAIWAN SWINE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95 REST OF SOUTH EAST ASIA SWINE VACCINES MARKET, BY PATHOGEN, 2018-2032 (USD MILLION)
图片列表
FIGURE 1 SOUTH EAST ASIA SWINE VACCINE MARKET: SEGMENTATION
FIGURE 2 SOUTH EAST ASIA SWINE VACCINE MARKET: DATA TRIANGULATION
FIGURE 3 SOUTH EAST ASIA SWINE VACCINE MARKET: DROC ANALYSIS
FIGURE 4 SOUTH EAST ASIA SWINE VACCINE MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 5 SOUTH EAST ASIA SWINE VACCINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SOUTH EAST ASIA SWINE VACCINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 SOUTH EAST ASIA SWINE VACCINE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 SOUTH EAST ASIA SWINE VACCINE MARKET: SEGMENTATION
FIGURE 9 SOUTH EAST ASIA SWINE VACCINE MARKET EXECUTIVE SUMMARY
FIGURE 10 STRATEGIC DECISIONS
FIGURE 11 RISING INCIDENCE OF SWINE DISEASES IS EXPECTED TO BOOST THE SOUTH EAST ASIA SWINE VACCINE MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 12 VIRUS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SOUTH EAST ASIA SWINE VACCINE MARKET IN 2025 & 2032
FIGURE 13 DROC ANALYSIS
FIGURE 14 SOUTH EAST ASIA SWINE VACCINES MARKET: BY TECHNOLOGY, 2024
FIGURE 15 SOUTH EAST ASIA SWINE VACCINES MARKET: BY TECHNOLOGY, 2025-2032 (USD MILLION)
FIGURE 16 SOUTH EAST ASIA SWINE VACCINES MARKET: BY TECHNOLOGY, CAGR (2025-2032)
FIGURE 17 SOUTH EAST ASIA SWINE VACCINES MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 18 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PRODUCT, 2024
FIGURE 19 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PRODUCT, 2025-2032 (USD MILLION)
FIGURE 20 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PRODUCT, CAGR (2025-2032)
FIGURE 21 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 22 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PATHOGEN, 2024
FIGURE 23 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PATHOGEN, 2025-2032 (USD MILLION)
FIGURE 24 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PATHOGEN, CAGR (2025-2032)
FIGURE 25 SOUTH EAST ASIA SWINE VACCINES MARKET: BY PATHOGEN, LIFELINE CURVE
FIGURE 26 SOUTH EAST ASIA SWINE VACCINES MARKET: BY INDICATION, 2024
FIGURE 27 SOUTH EAST ASIA SWINE VACCINES MARKET: BY INDICATION, 2025-2032 (USD MILLION)
FIGURE 28 SOUTH EAST ASIA SWINE VACCINES MARKET: BY INDICATION, CAGR (2025-2032)
FIGURE 29 SOUTH EAST ASIA SWINE VACCINES MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 30 SOUTH EAST ASIA SWINE VACCINE MARKET: BY DEMOGRAPHIC, 2024
FIGURE 31 SOUTH EAST ASIA SWINE VACCINE MARKET: BY DEMOGRAPHIC, 2025-2032 (USD MILLION)
FIGURE 32 SOUTH EAST ASIA SWINE VACCINE MARKET: BY DEMOGRAPHIC, CAGR (2025-2032)
FIGURE 33 SOUTH EAST ASIA SWINE VACCINE MARKET: BY DEMOGRAPHIC, LIFELINE CURVE
FIGURE 34 SOUTH EAST ASIA SWINE VACCINES MARKET: BY ROUTE OF ADMINISTRATION, 2024
FIGURE 35 SOUTH EAST ASIA SWINE VACCINES MARKET: BY ROUTE OF ADMINISTRATION E, 2025-2032 (USD MILLION)
FIGURE 36 SOUTH EAST ASIA SWINE VACCINES MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2025-2032)
FIGURE 37 SOUTH EAST ASIA SWINE VACCINES MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 38 SOUTH EAST ASIA SWINE VACCINES MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 39 SOUTH EAST ASIA SWINE VACCINES MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
FIGURE 40 SOUTH EAST ASIA SWINE VACCINES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 41 SOUTH EAST ASIA SWINE VACCINES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 SOUTH EAST ASIA SWINE VACCINES MARKET: SNAPSHOT (2024)
FIGURE 43 SOUTH EAST ASIA SWINE VACCINES MARKET: COMPANY SHARE 2024 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
